Cardiovascular consequences of endogenous opiate antagonism.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D004723:Endorphins / Q000097:blood / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists; D011311:Pressoreceptors / Q000502:physiology; D012769:Shock / Q000503:physiopathology; D012772:Shock, Septic / Q000097:blood; D013119:Spinal Cord Injuries / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014947:Wounds and Injuries / Q000503:physiopathology
D004723:Endorphins; D009292:Narcotic Antagonists; D009270:Naloxone; D013973:Thyrotropin-Releasing Hormone